Literature DB >> 6476212

Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. I. Attributes of uncloned virus at different passage levels.

S B Halstead, A R Diwan, N J Marchette, N E Palumbo, L Srisukonth.   

Abstract

Attempts were made to attenuate prototype dengue (DEN) 4 (H-241) virus. The original viremic human serum was passed once in a susceptible monkey and twice in Aedes albopictus mosquitoes and then serially passed in primary dog kidney (PDK) and African green monkey kidney (GMK) cells. Weekly transfers of undiluted virus were carried to the 50th passage in both primary cell cultures. Biological markers were studied at passages 7, 15, 30 and 50. Parental DEN-4 phenotype characteristics included large plaque formation in LLC-MK2 cells, plaque formation in GMK cells, cytopathic effect in LLC-MK2 cells, growth in human monocyte cultures, growth at 39 degrees C, consistent production of viremia in monkeys and short-incubation neurovirulence in mice. At the seventh passage in both PDK and GMK cell cultures, DEN-4 viruses exhibited reduced plaque-size in LLC-MK2, and failed to plaque in GMK, to produce cytopathic effect in LLC-MK2, or to grow in human monocytes. Serial passage in PDK, as opposed to GMK, resulted in a graduated loss of monkey virulence. Rhesus monkeys inoculated with the PDK 50 strain failed to develop detectable viremia and only 1 of 4 developed an antibody response. Also, replication of PDK 50 was completely shut-off at 39 degrees C. The graduated change in biological properties noted, particularly those in PDK cells, provide a range of potential vaccine candidates for evaluation in human beings.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476212     DOI: 10.4269/ajtmh.1984.33.654

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

1.  The necessity and quandaries of dengue vaccine development.

Authors:  Stephen J Thomas
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

2.  Genetic and biological differentiation of dengue 3 isolates obtained from clinical cases in Java, Indonesia, 1976-1978.

Authors:  E Lee; D J Gubler; R C Weir; L Dalgarno
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Escape Mutations in NS4B Render Dengue Virus Insensitive to the Antiviral Activity of the Paracetamol Metabolite AM404.

Authors:  Koen W R van Cleef; Gijs J Overheul; Michael C Thomassen; Jenni M Marjakangas; Ronald P van Rij
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

4.  Adaptation of two flaviviruses results in differences in genetic heterogeneity and virus adaptability.

Authors:  Alexander T Ciota; Amy O Lovelace; Susan A Jones; Anne Payne; Laura D Kramer
Journal:  J Gen Virol       Date:  2007-09       Impact factor: 3.891

Review 5.  Dengue and dengue hemorrhagic fever.

Authors:  D J Gubler
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

Review 6.  Insect-transmitted vertebrate viruses: flaviviridae.

Authors:  G V Ludwig; L C Iacono-Connors
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

Review 7.  Manipulation of cell surface macromolecules by flaviviruses.

Authors:  Robert Anderson
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.